Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.3556
-0.0021 (-0.59%)
Aug 7, 2026, 12:08 PM EST
Elite Pharmaceuticals Employees
Elite Pharmaceuticals had 65 employees as of March 31, 2026. The number of employees decreased by 3 or -4.41% compared to the previous year.
Employees
65
Change (1Y)
-3
Growth (1Y)
-4.41%
Revenue / Employee
$2,290,310
Profits / Employee
$690,349
Market Cap
385.28M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 65 | -3 | -4.41% |
| Mar 31, 2025 | 68 | 4 | 6.25% |
| Mar 31, 2024 | 64 | 11 | 20.75% |
| Mar 31, 2023 | 53 | 10 | 23.26% |
| Mar 31, 2022 | 43 | 0 | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MariMed | 923 |
| Earth Science Tech | 77 |
| Radnostix | 45 |
| Healthy Extracts | 22 |
| Bio Essence | 4 |
Elite Pharmaceuticals News
- 3 days ago - Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL - Newsfile Corp
- 5 weeks ago - Elite Pharmaceuticals Earnings Call Transcript: Q4 2026 - Transcripts
- 5 weeks ago - Elite Pharmaceuticals Annual report: Q4 2026 - Filings
- 5 weeks ago - Elite Pharmaceuticals Earnings release: Q4 2026 - Filings
- 5 weeks ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information - Newsfile Corp
- 6 weeks ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026 - Newsfile Corp
- 7 weeks ago - Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product - Newsfile Corp